Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02175576 · ClinicalTrials.gov registry record · NA
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02175576 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 50 participants.
The verdict
NCT02175576, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Randomized Controlled Study to determine if preservation of ligaments provides increased functional ability post-operatively in comparison to traditional TKA which sacrifices soft tissue.
Interventions
- DEVICE Vanguard XP Bicruciate Knee System
- DEVICE Vanguard CR Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02175576
The ClinicalTrials.gov registry entry for NCT02175576 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vanguard XP Bicruciate Knee System is the first listed.
NCT02175576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02175576 about?
NCT02175576 is a clinical study titled "Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System". Randomized Controlled Study to determine if preservation of ligaments provides increased functional ability post-operatively in comparison to traditional TKA which sacrifices soft tissue.
What is the current status of trial NCT02175576?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2014-10. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02175576?
The interventions under investigation include: Vanguard XP Bicruciate Knee System (DEVICE), Vanguard CR Knee System (DEVICE).
Who is sponsoring clinical trial NCT02175576?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.